Data as of Nov 4, 2026.
FEBU vs GJAN: Cap, Buffer & Days Left
As of Nov 4, 2026 GJAN can fall 8.1% before its buffer engages and FEBU 7.4%, and GJAN resets 16 days sooner.
askIQ about this page
askIQ about FEBU and GJANNet assets on Nov 3, 2026: $47m for AllianzIM U.S. Equity Buffer15 Uncapped ETF - Feb and $433m for FT Vest U.S. Equity Moderate Buffer ETF - January.
FEBU: reference +10.8% since period start, fund +7.1%; buffer 0 to −15; no cap; No cap. Data to Nov 4, 2026.
FEBU: reference +10.8% since period start, fund +7.1%; buffer 0 to −15; no cap; No cap. Data to Nov 4, 2026.GJAN: reference +10.8% since period start, fund +7.9%; buffer 0 to −15; cap +11.8%; Between buffer and cap. Data to Nov 4, 2026.
Data to Nov 4, 2026.Pair scorecard
FEBU costs 0.11 points a year less; their one-year returns differ by 1.7 points; GJAN is 9.2 times larger.
Points (pts) are percentage points.
| Measure | FEBU | GJAN |
|---|---|---|
| Return | ||
| Total return, 1 year | +9.0% | +10.7% |
| Drawdown | ||
| Index fall to the buffer | 9.8% | |
| Benchmark | ||
| What it tracks | SPY | SPY |
| Cost and size | ||
| Expense ratio | 0.74% | 0.85% |
| Net assets, as of Nov 3, 2026 | $47m | $433m |
| Holdings | ||
| Holdings in common | not published | |
How much of a bear-market fall the buffer would absorb from today's level, ranked against 292 buffer ETFs on stocks with a live outcome period. 100 is best. How it is computed
Today's position against one 20% fall; it ignores smaller falls, and stock buffers are never ranked against bond or commodity ones. All buffer ETFs ranked by it →
Window by window
| Total return | Gap to the reference's price return | |||
|---|---|---|---|---|
| Window | FEBU | GJAN | FEBU | GJAN |
| 3 months | −1.3% | +1.6% | −0.9 pts | +2.0 pts |
| 6 months | +2.3% | +4.4% | −2.2 pts | −0.1 pts |
| 1 year | +9.0% | +10.7% | −4.6 pts | −2.8 pts |
| 3 years | – | +41.9% | – | −34.5 pts |
| Since launchNot the same days: FEBU Feb 2025 · GJAN Jan 2023 | +19.7% | +52.7% | −8.6 pts | −38.7 pts |
Each fund's gap is to its reference's price return, dividends left out: the basis the outcome period uses. – means no data for this window. Open this comparison in the app →
Side by side
As of Nov 4, 2026. Source: ETFIQ.
Where each one stands today
GJAN resets first, on Jan 15, 2027, 72 days from now; FEBU runs to Jan 31, 2027, 88 days. A fall from here reaches FEBU’s buffer after 7.4% and GJAN’s after 8.1%. Both track SPY, so what separates them is where each is in its own period.
FEBU
This fund has no cap. It takes a share of any further rise in SPY. The fund's price can fall 7.4% from here before the buffer starts absorbing losses, by the issuer's number. In index terms, SPY can fall 9.8% from today's level to the point where the buffer begins. Protection left, in index points: 15.0% of the 15.0% buffer still sits below today's SPY level. 88 days remained on Nov 4, 2026. On Jan 31, 2027 the period ends and new terms are set.
GJAN
From its price on Nov 4, 2026, the fund can gain about 2.8% more before it reaches its cap. The fund's price can fall 8.1% from here before the buffer starts absorbing losses, by the issuer's number. 72 days remained on Nov 4, 2026. On Jan 15, 2027 the period ends and a new cap is set.
Questions people ask
Links are sources, not endorsements. A comparison is not a recommendation.
How this is computed
It is a place in a set, not a rating or a recommendation.
ETFIQ calculates every number from each issuer’s published outcome-period terms. Buffer ETFs hold options on an index, not shares, so there is no holdings overlap to report.
Every number is an ETFIQ calculation with distributions reinvested.
Cite this pageCitation, APA and Markdown
ETFIQ, FEBU against GJAN, data as of Nov 4, 2026. https://etfiq.com/compare/buffer/febu-vs-gjan
ETFIQ. (Nov 4, 2026). FEBU against GJAN. Retrieved from https://etfiq.com/compare/buffer/febu-vs-gjan
[FEBU against GJAN (ETFIQ, Nov 4, 2026)](https://etfiq.com/compare/buffer/febu-vs-gjan)
Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.